Editing Biochemical engineering (section)

=== Pharmaceuticals ===

In the pharmaceutical industry, bioprocess engineering plays a crucial role in the large-scale production of biopharmaceuticals, such as monoclonal antibodies, vaccines, and therapeutic proteins. The development and optimization of bioreactors and fermentation systems are essential for the mass production of these products, ensuring consistent quality and high yields. For example, recombinant proteins like insulin and erythropoietin are produced through cell culture systems using genetically modified cells. The bioprocess engineer’s role is to optimize variables like temperature, pH, nutrient availability, and oxygen levels to maximize the efficiency of these systems. The growing field of gene therapy also relies on bioprocessing techniques to produce viral vectors, which are used to deliver therapeutic genes to patients. This involves scaling up processes from laboratory to industrial scale while maintaining safety and regulatory compliance.<ref>{{Cite journal |author=Shukla, A. A. |author2=Thömmes, J. |author3=Hackl, M. |title=Recent advances in downstream processing of therapeutic monoclonal antibodies |journal=Biotechnology Advances |volume=30 |issue=3 |year=2012 |pages=1548–1557 |doi=10.1016/j.biotechadv.2012.04.003}}</ref> As the demand for biopharmaceutical products increases, advancements in bioprocess engineering continue to enable more sustainable and cost-effective manufacturing methods.